foxo4 dri peptide senolytic 2023 FOXO4-DRI For Sale (10mg) Peptide inhibitors targeting FOXO4-p53 interactions
Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOX04 DRI Apollo Peptide Sciences FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data
Pay in 4 interest-free payments of $5.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



